CRT-400.03 Effects of Angiotensin Receptor Neprilysin Inhibitor on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction
Abstract
Angiotensin receptor-neprilysin inhibitor (sacubitril/valsartan) is well known to be superior over angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blockers (ARBs) in terms of reducing cardiovascular mortality in heart failure with reduced ejection fraction (HFrEF)....
Paper Details
Title
CRT-400.03 Effects of Angiotensin Receptor Neprilysin Inhibitor on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction
Published Date
Feb 1, 2020
Volume
13
Issue
4
Pages
S40 - S41
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History